Kelly Long, Ms, Dabt
About Kelly Long, Ms, Dabt
Kelly Long, Ms, Dabt, serves as the Senior Director of Pharmacology & Toxicology at Inotiv, bringing extensive experience from previous roles at BASi, Pfizer, and Seventh Wave Laboratories. She specializes in osteoporosis and diabetes, with a strong background in nutrition and clinical project management.
Current Role at Inotiv
Kelly Long serves as the Senior Director of Pharmacology & Toxicology at Inotiv, a position she has held since 2020. In this role, she provides strategic input in pharmacology and toxicology, leveraging her extensive experience in the field. Her focus includes managing projects related to osteoporosis and diabetes, areas where she has developed specialized expertise.
Previous Experience in Pharmacology and Toxicology
Prior to her current role, Kelly Long held various positions in pharmacology and toxicology. She was the Director of Pharmacology & Toxicology at BASi from 2018 to 2020. Before that, she worked at Seventh Wave Laboratories LLC, where she served as Associate Director and Senior Study Director. Her experience also includes significant roles at Pfizer, where she progressed from Scientist to Principal Scientist over a span of several years.
Educational Background
Kelly Long earned her Bachelor of Science degree in Biology from Truman State University, completing her studies from 1992 to 1996. She furthered her education at the University of Illinois Urbana-Champaign, where she obtained a Master of Science in Food Science and Human Nutrition from 1996 to 1998. This educational foundation supports her expertise in pharmacology and toxicology.
Specialization and Expertise
Kelly Long specializes in pharmacology with a focus on osteoporosis and diabetes. Her expertise extends to steroid receptor biology, particularly glucocorticoid and estrogen receptors. Additionally, she has a background in nutrition and clinical project management, which enhances her ability to manage multiple tasks and foster collaborations in her field.
Research and Development Contributions
Throughout her career, Kelly Long has contributed to research and development in pharmacology and toxicology. Her roles have involved strategic planning and execution of studies, particularly in the areas of drug development and safety assessment. Her organizational skills have been instrumental in driving collaborations and managing complex projects.